| 1.4 |
7.0 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 1.2 |
4.8 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 1.2 |
3.5 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.9 |
2.8 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.8 |
4.0 |
GO:2000065 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.8 |
2.4 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.8 |
2.3 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.7 |
2.1 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.7 |
3.4 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.7 |
2.0 |
GO:0050929 |
corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.6 |
1.3 |
GO:0071672 |
negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.6 |
2.5 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
| 0.6 |
1.8 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.6 |
1.2 |
GO:1902566 |
regulation of eosinophil activation(GO:1902566) |
| 0.6 |
0.6 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.5 |
2.6 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.5 |
1.6 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.5 |
2.1 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.5 |
1.5 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.5 |
2.7 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.5 |
2.3 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) |
| 0.5 |
3.6 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.4 |
1.3 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.4 |
3.0 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.4 |
2.8 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.4 |
1.9 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.4 |
1.1 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) |
| 0.4 |
1.8 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.4 |
1.8 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.4 |
1.1 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.3 |
1.0 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 0.3 |
1.7 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.3 |
1.7 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.3 |
1.3 |
GO:2000974 |
negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.3 |
0.3 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 0.3 |
1.3 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.3 |
1.9 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.3 |
0.6 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.3 |
1.2 |
GO:0035934 |
corticosterone secretion(GO:0035934) |
| 0.3 |
0.9 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.3 |
2.1 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.3 |
2.1 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.3 |
0.9 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.3 |
2.9 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.3 |
1.4 |
GO:0071499 |
response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
| 0.3 |
4.2 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.3 |
0.8 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.3 |
1.4 |
GO:0021905 |
pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) |
| 0.3 |
1.7 |
GO:0010694 |
positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.3 |
0.8 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.3 |
2.7 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.3 |
1.6 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.3 |
0.8 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.3 |
1.3 |
GO:0086013 |
membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
| 0.3 |
0.8 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) |
| 0.3 |
1.0 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.3 |
0.8 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.3 |
1.0 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) |
| 0.3 |
1.8 |
GO:0032960 |
regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
| 0.2 |
1.2 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.2 |
3.3 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 0.2 |
0.7 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.2 |
0.9 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.2 |
3.1 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
0.7 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.2 |
0.2 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.2 |
1.1 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.2 |
0.9 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.2 |
4.1 |
GO:0032461 |
positive regulation of protein oligomerization(GO:0032461) |
| 0.2 |
1.3 |
GO:0030449 |
regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
| 0.2 |
0.6 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.2 |
1.1 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.2 |
0.8 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.2 |
2.2 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.2 |
0.6 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.2 |
1.0 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.2 |
0.6 |
GO:0006295 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.2 |
0.6 |
GO:0060423 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) negative regulation of mitotic cell cycle, embryonic(GO:0045976) foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
| 0.2 |
0.8 |
GO:0044650 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.2 |
1.7 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.2 |
1.5 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.2 |
0.9 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 |
1.6 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.2 |
0.2 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.2 |
1.0 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.2 |
0.9 |
GO:0045006 |
DNA deamination(GO:0045006) |
| 0.2 |
0.5 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.2 |
1.9 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.2 |
0.3 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.2 |
1.3 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.2 |
0.8 |
GO:0042167 |
heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 |
1.0 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.2 |
0.7 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.2 |
0.8 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.2 |
0.5 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.2 |
0.3 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.2 |
0.5 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.2 |
0.5 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.2 |
2.2 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 |
0.5 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.2 |
1.1 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.2 |
0.3 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.2 |
2.9 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.2 |
0.5 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.2 |
0.8 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.1 |
0.9 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.1 |
0.4 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.1 |
0.4 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.1 |
0.7 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.1 |
0.7 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.1 |
0.3 |
GO:0002238 |
response to molecule of fungal origin(GO:0002238) |
| 0.1 |
0.3 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.1 |
0.4 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.1 |
0.7 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.1 |
0.1 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
0.5 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.1 |
0.5 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 |
0.4 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.1 |
0.5 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
0.8 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.1 |
0.4 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.1 |
0.8 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.1 |
2.1 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.1 |
0.4 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.1 |
0.1 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.1 |
0.9 |
GO:1901550 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.1 |
1.2 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
1.3 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
0.6 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
1.4 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) |
| 0.1 |
0.8 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 |
0.8 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.2 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 |
0.9 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 |
0.8 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.3 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.6 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.1 |
0.3 |
GO:0060217 |
hemangioblast cell differentiation(GO:0060217) |
| 0.1 |
0.4 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 |
1.5 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 |
0.3 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.1 |
0.2 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.1 |
0.5 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
0.2 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.1 |
0.4 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) resolution of recombination intermediates(GO:0071139) |
| 0.1 |
0.2 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 |
0.4 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
| 0.1 |
0.9 |
GO:0060768 |
regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
| 0.1 |
0.8 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 |
0.3 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.1 |
2.2 |
GO:0046596 |
regulation of viral entry into host cell(GO:0046596) |
| 0.1 |
0.4 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.1 |
0.5 |
GO:1905049 |
negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.1 |
1.2 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 |
0.7 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.1 |
0.2 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.1 |
0.5 |
GO:1903020 |
positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.1 |
0.2 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.1 |
0.3 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.1 |
0.6 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 |
0.6 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.7 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.1 |
0.1 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.1 |
0.9 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.1 |
0.1 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 |
0.3 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.1 |
0.4 |
GO:2000002 |
negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.1 |
0.1 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.1 |
0.4 |
GO:0048682 |
axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
| 0.1 |
0.4 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.1 |
0.1 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
0.3 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.1 |
1.6 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.4 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.2 |
GO:0048007 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.1 |
0.3 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 |
0.3 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.1 |
0.3 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.1 |
0.8 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
| 0.1 |
0.9 |
GO:0044144 |
regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.1 |
0.4 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.1 |
0.6 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
0.5 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.1 |
0.1 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.1 |
0.1 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 0.1 |
0.7 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.1 |
0.8 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.1 |
0.4 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.2 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 |
0.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
1.7 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
1.9 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.1 |
0.2 |
GO:0035964 |
vesicle coating(GO:0006901) COPI-coated vesicle budding(GO:0035964) |
| 0.1 |
0.3 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.1 |
0.2 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.1 |
0.4 |
GO:0032902 |
nerve growth factor production(GO:0032902) |
| 0.1 |
0.2 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.1 |
0.1 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 |
0.2 |
GO:0060785 |
regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
| 0.1 |
0.2 |
GO:0000087 |
mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
| 0.1 |
0.7 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
0.4 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.1 |
0.4 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.1 |
0.2 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.1 |
0.8 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 |
0.4 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.1 |
1.0 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 |
0.9 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.1 |
0.4 |
GO:0021940 |
positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.1 |
0.9 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.1 |
0.4 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
0.2 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.1 |
0.3 |
GO:0019530 |
taurine metabolic process(GO:0019530) |
| 0.1 |
0.2 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 |
0.2 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 |
0.2 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.1 |
0.2 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.1 |
0.4 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 |
0.3 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.1 |
0.6 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.1 |
1.5 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.1 |
0.2 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.1 |
0.3 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.1 |
0.5 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.1 |
0.4 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 |
2.6 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 |
0.1 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
0.2 |
GO:0090069 |
regulation of ribosome biogenesis(GO:0090069) |
| 0.1 |
0.2 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.1 |
0.4 |
GO:0045061 |
thymic T cell selection(GO:0045061) |
| 0.1 |
0.9 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 |
1.0 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.1 |
0.1 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 |
0.2 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.1 |
0.2 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.1 |
0.2 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.1 |
6.2 |
GO:0048709 |
oligodendrocyte differentiation(GO:0048709) |
| 0.1 |
0.2 |
GO:1900451 |
postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.1 |
0.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.5 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 |
0.8 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.2 |
GO:0010814 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 |
2.1 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.1 |
0.3 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.1 |
0.9 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.1 |
0.2 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 |
0.1 |
GO:0014891 |
striated muscle atrophy(GO:0014891) |
| 0.1 |
0.8 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.1 |
0.2 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
0.2 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 |
0.4 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.1 |
1.1 |
GO:0006677 |
glycosylceramide metabolic process(GO:0006677) |
| 0.1 |
0.3 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.1 |
2.1 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
2.2 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.1 |
0.7 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.1 |
0.2 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.1 |
0.7 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.1 |
1.0 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.1 |
0.1 |
GO:0006533 |
aspartate catabolic process(GO:0006533) |
| 0.1 |
0.2 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 |
0.3 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 |
0.4 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.5 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.1 |
0.6 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.1 |
0.3 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.1 |
0.3 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
0.9 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.1 |
0.7 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
1.1 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.1 |
0.3 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
| 0.1 |
0.1 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.1 |
0.2 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 |
0.2 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 |
0.3 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
0.2 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.1 |
0.3 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.1 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.1 |
0.3 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.1 |
1.1 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
0.2 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.1 |
0.1 |
GO:0008078 |
mesodermal cell migration(GO:0008078) |
| 0.1 |
0.2 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
1.6 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 |
0.3 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 |
0.4 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.1 |
0.2 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.1 |
0.2 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 |
0.1 |
GO:0090269 |
fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.1 |
0.2 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.1 |
0.2 |
GO:1900864 |
positive regulation of translational fidelity(GO:0045903) mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 |
0.8 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.2 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.0 |
1.6 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.0 |
0.2 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.0 |
1.4 |
GO:0015909 |
long-chain fatty acid transport(GO:0015909) |
| 0.0 |
0.5 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.0 |
0.2 |
GO:0043173 |
purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) nucleotide salvage(GO:0043173) |
| 0.0 |
0.7 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.1 |
GO:2000619 |
negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.0 |
0.2 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.0 |
0.0 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.0 |
0.1 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.0 |
0.3 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
1.6 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 |
1.0 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.5 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.0 |
0.7 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.2 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.2 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.0 |
0.1 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.0 |
0.3 |
GO:0051608 |
histamine transport(GO:0051608) |
| 0.0 |
1.6 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.0 |
0.2 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.0 |
0.5 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
1.1 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.0 |
0.2 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.0 |
0.4 |
GO:0072337 |
modified amino acid transport(GO:0072337) |
| 0.0 |
0.6 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 |
0.5 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.2 |
GO:0030048 |
actin filament-based movement(GO:0030048) |
| 0.0 |
0.5 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.0 |
0.3 |
GO:0044406 |
adhesion of symbiont to host(GO:0044406) |
| 0.0 |
0.2 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.0 |
0.6 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.0 |
0.2 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.0 |
0.2 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.0 |
0.9 |
GO:0034340 |
response to type I interferon(GO:0034340) |
| 0.0 |
0.1 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.0 |
0.3 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.0 |
0.0 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.0 |
0.1 |
GO:0021898 |
commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.0 |
0.7 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.0 |
0.1 |
GO:0031126 |
snoRNA 3'-end processing(GO:0031126) |
| 0.0 |
0.2 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.0 |
0.7 |
GO:0030890 |
positive regulation of B cell proliferation(GO:0030890) |
| 0.0 |
0.2 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.0 |
0.4 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
2.6 |
GO:0042742 |
defense response to bacterium(GO:0042742) |
| 0.0 |
0.0 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.0 |
0.8 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.0 |
0.6 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.0 |
0.7 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.0 |
0.5 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.0 |
0.1 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.0 |
3.0 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 |
0.2 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.0 |
0.2 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.0 |
0.3 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 |
0.1 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.0 |
0.1 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.0 |
0.2 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.0 |
0.5 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.0 |
0.1 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.0 |
0.1 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.0 |
3.4 |
GO:0098792 |
xenophagy(GO:0098792) |
| 0.0 |
0.1 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.0 |
0.1 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.0 |
0.1 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.0 |
0.2 |
GO:1901984 |
negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
| 0.0 |
0.1 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.0 |
0.1 |
GO:0048701 |
embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.0 |
0.6 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.0 |
0.1 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
| 0.0 |
0.2 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 |
0.1 |
GO:0034116 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.0 |
0.4 |
GO:0061036 |
positive regulation of cartilage development(GO:0061036) |
| 0.0 |
0.2 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.0 |
0.2 |
GO:0019915 |
lipid storage(GO:0019915) |
| 0.0 |
1.1 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.1 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.0 |
0.1 |
GO:0035511 |
oxidative DNA demethylation(GO:0035511) |
| 0.0 |
0.2 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.0 |
0.1 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.0 |
0.8 |
GO:0043297 |
apical junction assembly(GO:0043297) |
| 0.0 |
0.2 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 |
0.4 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.3 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 |
0.1 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.0 |
0.2 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 |
1.5 |
GO:0051289 |
protein homotetramerization(GO:0051289) |
| 0.0 |
0.1 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
| 0.0 |
0.1 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
0.2 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.0 |
0.3 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.0 |
0.2 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.1 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.0 |
0.1 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.0 |
0.1 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.0 |
0.1 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.0 |
0.1 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.0 |
0.1 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.0 |
0.1 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.0 |
0.2 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.2 |
GO:0050691 |
regulation of defense response to virus by host(GO:0050691) |
| 0.0 |
0.1 |
GO:0042891 |
antibiotic transport(GO:0042891) |
| 0.0 |
0.6 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
0.3 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.0 |
0.1 |
GO:0044828 |
negative regulation by host of viral process(GO:0044793) negative regulation by host of viral genome replication(GO:0044828) |
| 0.0 |
0.1 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.0 |
0.2 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.0 |
0.0 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.0 |
0.5 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 |
0.2 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
| 0.0 |
0.1 |
GO:0045342 |
MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.0 |
0.2 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
0.5 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
0.5 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.3 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 |
0.3 |
GO:0043045 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.0 |
0.3 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.0 |
0.2 |
GO:2000191 |
regulation of fatty acid transport(GO:2000191) |
| 0.0 |
0.1 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.0 |
0.2 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.0 |
0.3 |
GO:0044818 |
mitotic G2/M transition checkpoint(GO:0044818) |
| 0.0 |
0.9 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.0 |
0.0 |
GO:0009256 |
10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.0 |
0.1 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.0 |
0.1 |
GO:0042996 |
regulation of Golgi to plasma membrane protein transport(GO:0042996) |
| 0.0 |
0.5 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
| 0.0 |
0.2 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.0 |
0.1 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.0 |
0.1 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.0 |
0.2 |
GO:0002031 |
G-protein coupled receptor internalization(GO:0002031) |
| 0.0 |
0.1 |
GO:0046103 |
ADP biosynthetic process(GO:0006172) inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
| 0.0 |
0.2 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 |
0.5 |
GO:0048002 |
antigen processing and presentation of peptide antigen(GO:0048002) |
| 0.0 |
0.1 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.0 |
0.0 |
GO:0034182 |
regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.0 |
0.0 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 0.0 |
0.5 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.2 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.0 |
0.4 |
GO:0022617 |
extracellular matrix disassembly(GO:0022617) |
| 0.0 |
0.2 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.0 |
0.1 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 |
0.1 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 |
0.4 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.6 |
GO:0060479 |
lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
| 0.0 |
0.2 |
GO:0010039 |
response to iron ion(GO:0010039) |
| 0.0 |
0.6 |
GO:0042632 |
cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.0 |
0.8 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.0 |
0.1 |
GO:0051798 |
positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.0 |
0.3 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.0 |
0.1 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.0 |
0.1 |
GO:0051126 |
negative regulation of actin nucleation(GO:0051126) |
| 0.0 |
0.2 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.0 |
0.1 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 0.0 |
0.1 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.0 |
0.4 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.0 |
0.4 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 |
0.3 |
GO:0016572 |
histone phosphorylation(GO:0016572) |
| 0.0 |
0.0 |
GO:0044336 |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.0 |
0.1 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.0 |
0.0 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.0 |
0.2 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.0 |
0.2 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.0 |
0.3 |
GO:0030819 |
positive regulation of cAMP biosynthetic process(GO:0030819) |
| 0.0 |
0.2 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.6 |
GO:0061178 |
regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
| 0.0 |
0.2 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.0 |
0.2 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.0 |
0.1 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.0 |
0.0 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.0 |
0.0 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.0 |
0.2 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 |
0.1 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.0 |
1.1 |
GO:0006821 |
chloride transport(GO:0006821) |
| 0.0 |
0.2 |
GO:0002053 |
positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.0 |
0.2 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.0 |
0.1 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.0 |
0.0 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.0 |
0.2 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.0 |
0.2 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.0 |
0.1 |
GO:1900181 |
negative regulation of protein localization to nucleus(GO:1900181) |
| 0.0 |
0.1 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.0 |
0.2 |
GO:1903427 |
negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.0 |
0.6 |
GO:0009063 |
cellular amino acid catabolic process(GO:0009063) |
| 0.0 |
0.1 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.0 |
0.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.3 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.0 |
0.1 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.0 |
0.1 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.0 |
GO:0042267 |
natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.0 |
0.1 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.0 |
0.4 |
GO:0030500 |
regulation of bone mineralization(GO:0030500) |
| 0.0 |
0.1 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.0 |
0.1 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 |
0.3 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.0 |
0.2 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.0 |
0.1 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.0 |
0.2 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 |
0.2 |
GO:0042026 |
protein refolding(GO:0042026) |
| 0.0 |
0.2 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.1 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.0 |
0.2 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.2 |
GO:0000060 |
protein import into nucleus, translocation(GO:0000060) |
| 0.0 |
0.9 |
GO:0007050 |
cell cycle arrest(GO:0007050) |
| 0.0 |
0.1 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.0 |
0.2 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.0 |
0.0 |
GO:0032466 |
negative regulation of cytokinesis(GO:0032466) |
| 0.0 |
0.2 |
GO:0032438 |
melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
| 0.0 |
0.1 |
GO:0033273 |
response to vitamin(GO:0033273) |
| 0.0 |
0.1 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
